These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33679698)

  • 1. Trained Immunity-Based Vaccine in B Cell Hematological Malignancies With Recurrent Infections: A New Therapeutic Approach.
    Ochoa-Grullón J; Benavente Cuesta C; González Fernández A; Cordero Torres G; Pérez López C; Peña Cortijo A; Conejero Hall L; Mateo Morales M; Rodríguez de la Peña A; Díez-Rivero CM; Rodríguez de Frías E; Guevara-Hoyer K; Fernández-Arquero M; Sánchez-Ramón S
    Front Immunol; 2020; 11():611566. PubMed ID: 33679698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual Bacterial Vaccination Reduces Recurrent Infections in Patients With Autoimmune Diseases Under Immunosuppressant Treatment.
    Sánchez-Ramón S; Fernández-Paredes L; Saz-Leal P; Diez-Rivero CM; Ochoa-Grullón J; Morado C; Macarrón P; Martínez C; Villaverde V; de la Peña AR; Conejero L; Hernández-Llano K; Cordero G; Fernández-Arquero M; Gutierrez BF; Candelas G
    Front Immunol; 2021; 12():675735. PubMed ID: 34149711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trained Immunity Based-Vaccines as a Prophylactic Strategy in Common Variable Immunodeficiency. A Proof of Concept Study.
    Guevara-Hoyer K; Saz-Leal P; Diez-Rivero CM; Ochoa-Grullón J; Fernández-Arquero M; Pérez de Diego R; Sánchez-Ramón S
    Biomedicines; 2020 Jul; 8(7):. PubMed ID: 32660100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways.
    Cirauqui C; Benito-Villalvilla C; Sánchez-Ramón S; Sirvent S; Diez-Rivero CM; Conejero L; Brandi P; Hernández-Cillero L; Ochoa JL; Pérez-Villamil B; Sancho D; Subiza JL; Palomares O
    Eur J Immunol; 2018 Jan; 48(1):180-193. PubMed ID: 28799230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MV130 in the Prevention of Recurrent Respiratory Tract Infections: A Retrospective Real-World Study in Children and Adults.
    Montalbán-Hernández K; Cogollo-García A; Girón de Velasco-Sada P; Caballero R; Casanovas M; Subiza JL; Conejero L
    Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections.
    Brandi P; Conejero L; Cueto FJ; Martínez-Cano S; Dunphy G; Gómez MJ; Relaño C; Saz-Leal P; Enamorado M; Quintas A; Dopazo A; Amores-Iniesta J; Del Fresno C; Nistal-Villán E; Ardavín C; Nieto A; Casanovas M; Subiza JL; Sancho D
    Cell Rep; 2022 Jan; 38(1):110184. PubMed ID: 34986349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Combination of Polybacterial MV140 and
    Martin-Cruz L; Sevilla-Ortega C; Benito-Villalvilla C; Diez-Rivero CM; Sanchez-Ramón S; Subiza JL; Palomares O
    Front Immunol; 2020; 11():612269. PubMed ID: 33552074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Mesenchymal Stem Cells in Oral Mucosal Bacterial Immunotherapy.
    Vázquez A; Fernández-Sevilla LM; Jiménez E; Pérez-Cabrera D; Yañez R; Subiza JL; Varas A; Valencia J; Vicente A
    Front Immunol; 2020; 11():567391. PubMed ID: 33329530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome.
    Alecsandru D; Valor L; Sánchez-Ramón S; Gil J; Carbone J; Navarro J; Rodríguez J; Rodríguez-Sainz C; Fernández-Cruz E
    Clin Exp Immunol; 2011 Apr; 164(1):100–7. PubMed ID: 21391984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
    Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM, IgA and IgG response to conjugate polysaccharides in children with recurrent respiratory infections.
    Cavaliere FM; Graziani S; Del Duca E; Bilotta C; Sgrulletti M; Quinti I; Moschese V
    Scand J Immunol; 2021 Jan; 93(1):e12955. PubMed ID: 32767783
    [No Abstract]   [Full Text] [Related]  

  • 12. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
    Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
    Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
    Nieto A; Mazón A; Nieto M; Calderón R; Calaforra S; Selva B; Uixera S; Palao MJ; Brandi P; Conejero L; Saz-Leal P; Fernández-Pérez C; Sancho D; Subiza JL; Casanovas M
    Am J Respir Crit Care Med; 2021 Aug; 204(4):462-472. PubMed ID: 33705665
    [No Abstract]   [Full Text] [Related]  

  • 14. Mucosal bacterial immunotherapy with MV130 highly reduces the need of tonsillectomy in adults with recurrent tonsillitis.
    García González LA; Arrutia Díez F
    Hum Vaccin Immunother; 2019; 15(9):2150-2153. PubMed ID: 30779677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunological evaluation of patients with mild IgG1 deficiency.
    Van Kessel DA; Horikx PE; Van Houte AJ; De Graaff CS; Van Velzen-Blad H; Rijkers GT
    Clin Exp Immunol; 1999 Oct; 118(1):102-7. PubMed ID: 10540166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed
    Bodas-Pinedo A; Lafuente EM; Pelaez-Prestel HF; Ras-Carmona A; Subiza JL; Reche PA
    Front Immunol; 2023; 14():1235053. PubMed ID: 37675108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors in HIV-1-infected patients developing repetitive bacterial infections: toxicological, clinical, specific antibody class responses, opsonophagocytosis and Fc(gamma) RIIa polymorphism characteristics.
    Payeras A; Martinez P; Milà J; Riera M; Pareja A; Casal J; Matamoros N
    Clin Exp Immunol; 2002 Nov; 130(2):271-8. PubMed ID: 12390315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistent yellow nail syndrome and selective antibody deficiency.
    Bokszczanin A; Levinson AI
    Ann Allergy Asthma Immunol; 2003 Nov; 91(5):496-500. PubMed ID: 14692436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection.
    Esposito S; Marchisio P; Prada E; Daleno C; Porretti L; Carsetti R; Bosco A; Ierardi V; Scala A; Principi N
    Vaccine; 2014 May; 32(22):2546-52. PubMed ID: 24681270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of sublingual polyvalent bacterial vaccine (Lantigen B) in children with recurrent respiratory infection: a randomized double-blind controlled clinical trial].
    Chen AH; Chen RC; Zhang CQ; Chen D; Huang S; Lin Y; Zhan J; Zhong N
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):463-4. PubMed ID: 15265442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.